Daniel van den Bergh(42)

Kaiser Permanente Ventures Principal

Photo of Daniel van den Bergh, Principal at Kaiser Permanente Ventures
Oakland, California
$5.0m - $16.0m
$8.0m
Enterprise healthcare IT, digital health, healthcare services, medical technology
KP Ventures does not invest: - in drug development (biotech) - outside of the US - in businesses that would compete with parts of Kaiser Permanente (Medicare Advantage plans, for example)
CompanyDeal TypeAmountDate
NuvoloSeries B$12M (Lead)Jul 2019
NextHealth TechnologiesSeries B$20MMar 2019
Collective Medical TechnologiesSeries A$47.5MNov 2017
ProtenusSeries A$7M (Lead)Jul 2017
QuantiaMDSeries E$12MAug 2013
Sotera WirelessSeries D1$15MMay 2013
PrognosSeries B$15MMay 2013
NuPathePIPE$28MOct 2012
Putney VetSeries C$21M (Lead)Sep 2011
Advanced BiohealingAcquisition$750MMay 2011
The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering
No media found for Daniel van den Bergh.
cb
Photo of Topher Conway, Managing Partner at SV Angel
Photo of Ben Blume, Principal at Atomico

Atomico

Photo of Amy	 Belt Raimundo, Managing Director at Kaiser Permanente Ventures

Kaiser Permanente Ventures

Photo of Sarah Downey, Principal at Accomplice

Accomplice